BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22308486)

  • 1. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
    Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
    Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
    Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
    ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of KCNJ5 in familial and sporadic primary aldosteronism.
    Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
    Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
    Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
    J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells.
    Hardege I; Xu S; Gordon RD; Thompson AJ; Figg N; Stowasser M; Murrell-Lagnado R; O'Shaughnessy KM
    Mol Endocrinol; 2015 Oct; 29(10):1522-30. PubMed ID: 26340408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism and potassium channel mutations.
    Stowasser M
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
    Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
    Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
    Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.